Global Alpha L-Iduronidase Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 20 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Alpha L-Iduronidase market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).

This report studies the global Alpha L-Iduronidase production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Alpha L-Iduronidase, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alpha L-Iduronidase that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Alpha L-Iduronidase total production and demand, 2018-2029, (K Units)
Global Alpha L-Iduronidase total production value, 2018-2029, (USD Million)
Global Alpha L-Iduronidase production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Alpha L-Iduronidase consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Alpha L-Iduronidase domestic production, consumption, key domestic manufacturers and share
Global Alpha L-Iduronidase production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Alpha L-Iduronidase production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Alpha L-Iduronidase production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Alpha L-Iduronidase market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc and Ossianix Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Alpha L-Iduronidase market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Alpha L-Iduronidase Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Alpha L-Iduronidase Market, Segmentation by Type
    IDUA
    EC 3.2.1.76

Global Alpha L-Iduronidase Market, Segmentation by Application
    Oncology
    Dermatology
    Immunology
    Musculoskeletal Disorders

Companies Profiled:
    ArmaGen Inc
    BioStrategies LC
    Denali Therapeutics Inc
    EdiGene Inc
    Gain Therapeutics Inc
    Immusoft Corp
    JCR Pharmaceuticals Co Ltd
    Orchard Therapeutics Plc
    Ossianix Inc
    Rain Bio Inc
    RegenxBio Inc
    Tega Therapeutics Inc

Key Questions Answered
1. How big is the global Alpha L-Iduronidase market?
2. What is the demand of the global Alpha L-Iduronidase market?
3. What is the year over year growth of the global Alpha L-Iduronidase market?
4. What is the production and production value of the global Alpha L-Iduronidase market?
5. Who are the key producers in the global Alpha L-Iduronidase market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Alpha L-Iduronidase Introduction
    1.2 World Alpha L-Iduronidase Supply & Forecast
        1.2.1 World Alpha L-Iduronidase Production Value (2018 & 2022 & 2029)
        1.2.2 World Alpha L-Iduronidase Production (2018-2029)
        1.2.3 World Alpha L-Iduronidase Pricing Trends (2018-2029)
    1.3 World Alpha L-Iduronidase Production by Region (Based on Production Site)
        1.3.1 World Alpha L-Iduronidase Production Value by Region (2018-2029)
        1.3.2 World Alpha L-Iduronidase Production by Region (2018-2029)
        1.3.3 World Alpha L-Iduronidase Average Price by Region (2018-2029)
        1.3.4 North America Alpha L-Iduronidase Production (2018-2029)
        1.3.5 Europe Alpha L-Iduronidase Production (2018-2029)
        1.3.6 China Alpha L-Iduronidase Production (2018-2029)
        1.3.7 Japan Alpha L-Iduronidase Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Alpha L-Iduronidase Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Alpha L-Iduronidase Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Alpha L-Iduronidase Demand (2018-2029)
    2.2 World Alpha L-Iduronidase Consumption by Region
        2.2.1 World Alpha L-Iduronidase Consumption by Region (2018-2023)
        2.2.2 World Alpha L-Iduronidase Consumption Forecast by Region (2024-2029)
    2.3 United States Alpha L-Iduronidase Consumption (2018-2029)
    2.4 China Alpha L-Iduronidase Consumption (2018-2029)
    2.5 Europe Alpha L-Iduronidase Consumption (2018-2029)
    2.6 Japan Alpha L-Iduronidase Consumption (2018-2029)
    2.7 South Korea Alpha L-Iduronidase Consumption (2018-2029)
    2.8 ASEAN Alpha L-Iduronidase Consumption (2018-2029)
    2.9 India Alpha L-Iduronidase Consumption (2018-2029)

3 World Alpha L-Iduronidase Manufacturers Competitive Analysis
    3.1 World Alpha L-Iduronidase Production Value by Manufacturer (2018-2023)
    3.2 World Alpha L-Iduronidase Production by Manufacturer (2018-2023)
    3.3 World Alpha L-Iduronidase Average Price by Manufacturer (2018-2023)
    3.4 Alpha L-Iduronidase Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Alpha L-Iduronidase Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Alpha L-Iduronidase in 2022
        3.5.3 Global Concentration Ratios (CR8) for Alpha L-Iduronidase in 2022
    3.6 Alpha L-Iduronidase Market: Overall Company Footprint Analysis
        3.6.1 Alpha L-Iduronidase Market: Region Footprint
        3.6.2 Alpha L-Iduronidase Market: Company Product Type Footprint
        3.6.3 Alpha L-Iduronidase Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Alpha L-Iduronidase Production Value Comparison
        4.1.1 United States VS China: Alpha L-Iduronidase Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Alpha L-Iduronidase Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Alpha L-Iduronidase Production Comparison
        4.2.1 United States VS China: Alpha L-Iduronidase Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Alpha L-Iduronidase Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Alpha L-Iduronidase Consumption Comparison
        4.3.1 United States VS China: Alpha L-Iduronidase Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Alpha L-Iduronidase Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Alpha L-Iduronidase Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Alpha L-Iduronidase Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Alpha L-Iduronidase Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Alpha L-Iduronidase Production (2018-2023)
    4.5 China Based Alpha L-Iduronidase Manufacturers and Market Share
        4.5.1 China Based Alpha L-Iduronidase Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Alpha L-Iduronidase Production Value (2018-2023)
        4.5.3 China Based Manufacturers Alpha L-Iduronidase Production (2018-2023)
    4.6 Rest of World Based Alpha L-Iduronidase Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Alpha L-Iduronidase Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Alpha L-Iduronidase Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Alpha L-Iduronidase Production (2018-2023)

5 Market Analysis by Type
    5.1 World Alpha L-Iduronidase Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 IDUA
        5.2.2 EC 3.2.1.76
    5.3 Market Segment by Type
        5.3.1 World Alpha L-Iduronidase Production by Type (2018-2029)
        5.3.2 World Alpha L-Iduronidase Production Value by Type (2018-2029)
        5.3.3 World Alpha L-Iduronidase Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Alpha L-Iduronidase Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Oncology
        6.2.2 Dermatology
        6.2.3 Immunology
        6.2.4 Musculoskeletal Disorders
    6.3 Market Segment by Application
        6.3.1 World Alpha L-Iduronidase Production by Application (2018-2029)
        6.3.2 World Alpha L-Iduronidase Production Value by Application (2018-2029)
        6.3.3 World Alpha L-Iduronidase Average Price by Application (2018-2029)

7 Company Profiles
    7.1 ArmaGen Inc
        7.1.1 ArmaGen Inc Details
        7.1.2 ArmaGen Inc Major Business
        7.1.3 ArmaGen Inc Alpha L-Iduronidase Product and Services
        7.1.4 ArmaGen Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 ArmaGen Inc Recent Developments/Updates
        7.1.6 ArmaGen Inc Competitive Strengths & Weaknesses
    7.2 BioStrategies LC
        7.2.1 BioStrategies LC Details
        7.2.2 BioStrategies LC Major Business
        7.2.3 BioStrategies LC Alpha L-Iduronidase Product and Services
        7.2.4 BioStrategies LC Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 BioStrategies LC Recent Developments/Updates
        7.2.6 BioStrategies LC Competitive Strengths & Weaknesses
    7.3 Denali Therapeutics Inc
        7.3.1 Denali Therapeutics Inc Details
        7.3.2 Denali Therapeutics Inc Major Business
        7.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Product and Services
        7.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Denali Therapeutics Inc Recent Developments/Updates
        7.3.6 Denali Therapeutics Inc Competitive Strengths & Weaknesses
    7.4 EdiGene Inc
        7.4.1 EdiGene Inc Details
        7.4.2 EdiGene Inc Major Business
        7.4.3 EdiGene Inc Alpha L-Iduronidase Product and Services
        7.4.4 EdiGene Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 EdiGene Inc Recent Developments/Updates
        7.4.6 EdiGene Inc Competitive Strengths & Weaknesses
    7.5 Gain Therapeutics Inc
        7.5.1 Gain Therapeutics Inc Details
        7.5.2 Gain Therapeutics Inc Major Business
        7.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Product and Services
        7.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Gain Therapeutics Inc Recent Developments/Updates
        7.5.6 Gain Therapeutics Inc Competitive Strengths & Weaknesses
    7.6 Immusoft Corp
        7.6.1 Immusoft Corp Details
        7.6.2 Immusoft Corp Major Business
        7.6.3 Immusoft Corp Alpha L-Iduronidase Product and Services
        7.6.4 Immusoft Corp Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Immusoft Corp Recent Developments/Updates
        7.6.6 Immusoft Corp Competitive Strengths & Weaknesses
    7.7 JCR Pharmaceuticals Co Ltd
        7.7.1 JCR Pharmaceuticals Co Ltd Details
        7.7.2 JCR Pharmaceuticals Co Ltd Major Business
        7.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product and Services
        7.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 JCR Pharmaceuticals Co Ltd Recent Developments/Updates
        7.7.6 JCR Pharmaceuticals Co Ltd Competitive Strengths & Weaknesses
    7.8 Orchard Therapeutics Plc
        7.8.1 Orchard Therapeutics Plc Details
        7.8.2 Orchard Therapeutics Plc Major Business
        7.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Product and Services
        7.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Orchard Therapeutics Plc Recent Developments/Updates
        7.8.6 Orchard Therapeutics Plc Competitive Strengths & Weaknesses
    7.9 Ossianix Inc
        7.9.1 Ossianix Inc Details
        7.9.2 Ossianix Inc Major Business
        7.9.3 Ossianix Inc Alpha L-Iduronidase Product and Services
        7.9.4 Ossianix Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Ossianix Inc Recent Developments/Updates
        7.9.6 Ossianix Inc Competitive Strengths & Weaknesses
    7.10 Rain Bio Inc
        7.10.1 Rain Bio Inc Details
        7.10.2 Rain Bio Inc Major Business
        7.10.3 Rain Bio Inc Alpha L-Iduronidase Product and Services
        7.10.4 Rain Bio Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Rain Bio Inc Recent Developments/Updates
        7.10.6 Rain Bio Inc Competitive Strengths & Weaknesses
    7.11 RegenxBio Inc
        7.11.1 RegenxBio Inc Details
        7.11.2 RegenxBio Inc Major Business
        7.11.3 RegenxBio Inc Alpha L-Iduronidase Product and Services
        7.11.4 RegenxBio Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 RegenxBio Inc Recent Developments/Updates
        7.11.6 RegenxBio Inc Competitive Strengths & Weaknesses
    7.12 Tega Therapeutics Inc
        7.12.1 Tega Therapeutics Inc Details
        7.12.2 Tega Therapeutics Inc Major Business
        7.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Product and Services
        7.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Tega Therapeutics Inc Recent Developments/Updates
        7.12.6 Tega Therapeutics Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Alpha L-Iduronidase Industry Chain
    8.2 Alpha L-Iduronidase Upstream Analysis
        8.2.1 Alpha L-Iduronidase Core Raw Materials
        8.2.2 Main Manufacturers of Alpha L-Iduronidase Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Alpha L-Iduronidase Production Mode
    8.6 Alpha L-Iduronidase Procurement Model
    8.7 Alpha L-Iduronidase Industry Sales Model and Sales Channels
        8.7.1 Alpha L-Iduronidase Sales Model
        8.7.2 Alpha L-Iduronidase Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Alpha L-Iduronidase Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Alpha L-Iduronidase Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Alpha L-Iduronidase Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Alpha L-Iduronidase Production Value Market Share by Region (2018-2023)
    Table 5. World Alpha L-Iduronidase Production Value Market Share by Region (2024-2029)
    Table 6. World Alpha L-Iduronidase Production by Region (2018-2023) & (K Units)
    Table 7. World Alpha L-Iduronidase Production by Region (2024-2029) & (K Units)
    Table 8. World Alpha L-Iduronidase Production Market Share by Region (2018-2023)
    Table 9. World Alpha L-Iduronidase Production Market Share by Region (2024-2029)
    Table 10. World Alpha L-Iduronidase Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Alpha L-Iduronidase Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Alpha L-Iduronidase Major Market Trends
    Table 13. World Alpha L-Iduronidase Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Alpha L-Iduronidase Consumption by Region (2018-2023) & (K Units)
    Table 15. World Alpha L-Iduronidase Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Alpha L-Iduronidase Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Alpha L-Iduronidase Producers in 2022
    Table 18. World Alpha L-Iduronidase Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Alpha L-Iduronidase Producers in 2022
    Table 20. World Alpha L-Iduronidase Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Alpha L-Iduronidase Company Evaluation Quadrant
    Table 22. World Alpha L-Iduronidase Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Alpha L-Iduronidase Production Site of Key Manufacturer
    Table 24. Alpha L-Iduronidase Market: Company Product Type Footprint
    Table 25. Alpha L-Iduronidase Market: Company Product Application Footprint
    Table 26. Alpha L-Iduronidase Competitive Factors
    Table 27. Alpha L-Iduronidase New Entrant and Capacity Expansion Plans
    Table 28. Alpha L-Iduronidase Mergers & Acquisitions Activity
    Table 29. United States VS China Alpha L-Iduronidase Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Alpha L-Iduronidase Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Alpha L-Iduronidase Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Alpha L-Iduronidase Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Alpha L-Iduronidase Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Alpha L-Iduronidase Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Alpha L-Iduronidase Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Alpha L-Iduronidase Production Market Share (2018-2023)
    Table 37. China Based Alpha L-Iduronidase Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Alpha L-Iduronidase Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Alpha L-Iduronidase Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Alpha L-Iduronidase Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Alpha L-Iduronidase Production Market Share (2018-2023)
    Table 42. Rest of World Based Alpha L-Iduronidase Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Alpha L-Iduronidase Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Alpha L-Iduronidase Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Alpha L-Iduronidase Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Alpha L-Iduronidase Production Market Share (2018-2023)
    Table 47. World Alpha L-Iduronidase Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Alpha L-Iduronidase Production by Type (2018-2023) & (K Units)
    Table 49. World Alpha L-Iduronidase Production by Type (2024-2029) & (K Units)
    Table 50. World Alpha L-Iduronidase Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Alpha L-Iduronidase Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Alpha L-Iduronidase Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Alpha L-Iduronidase Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Alpha L-Iduronidase Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Alpha L-Iduronidase Production by Application (2018-2023) & (K Units)
    Table 56. World Alpha L-Iduronidase Production by Application (2024-2029) & (K Units)
    Table 57. World Alpha L-Iduronidase Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Alpha L-Iduronidase Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Alpha L-Iduronidase Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Alpha L-Iduronidase Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. ArmaGen Inc Basic Information, Manufacturing Base and Competitors
    Table 62. ArmaGen Inc Major Business
    Table 63. ArmaGen Inc Alpha L-Iduronidase Product and Services
    Table 64. ArmaGen Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. ArmaGen Inc Recent Developments/Updates
    Table 66. ArmaGen Inc Competitive Strengths & Weaknesses
    Table 67. BioStrategies LC Basic Information, Manufacturing Base and Competitors
    Table 68. BioStrategies LC Major Business
    Table 69. BioStrategies LC Alpha L-Iduronidase Product and Services
    Table 70. BioStrategies LC Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. BioStrategies LC Recent Developments/Updates
    Table 72. BioStrategies LC Competitive Strengths & Weaknesses
    Table 73. Denali Therapeutics Inc Basic Information, Manufacturing Base and Competitors
    Table 74. Denali Therapeutics Inc Major Business
    Table 75. Denali Therapeutics Inc Alpha L-Iduronidase Product and Services
    Table 76. Denali Therapeutics Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Denali Therapeutics Inc Recent Developments/Updates
    Table 78. Denali Therapeutics Inc Competitive Strengths & Weaknesses
    Table 79. EdiGene Inc Basic Information, Manufacturing Base and Competitors
    Table 80. EdiGene Inc Major Business
    Table 81. EdiGene Inc Alpha L-Iduronidase Product and Services
    Table 82. EdiGene Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. EdiGene Inc Recent Developments/Updates
    Table 84. EdiGene Inc Competitive Strengths & Weaknesses
    Table 85. Gain Therapeutics Inc Basic Information, Manufacturing Base and Competitors
    Table 86. Gain Therapeutics Inc Major Business
    Table 87. Gain Therapeutics Inc Alpha L-Iduronidase Product and Services
    Table 88. Gain Therapeutics Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Gain Therapeutics Inc Recent Developments/Updates
    Table 90. Gain Therapeutics Inc Competitive Strengths & Weaknesses
    Table 91. Immusoft Corp Basic Information, Manufacturing Base and Competitors
    Table 92. Immusoft Corp Major Business
    Table 93. Immusoft Corp Alpha L-Iduronidase Product and Services
    Table 94. Immusoft Corp Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Immusoft Corp Recent Developments/Updates
    Table 96. Immusoft Corp Competitive Strengths & Weaknesses
    Table 97. JCR Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
    Table 98. JCR Pharmaceuticals Co Ltd Major Business
    Table 99. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product and Services
    Table 100. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. JCR Pharmaceuticals Co Ltd Recent Developments/Updates
    Table 102. JCR Pharmaceuticals Co Ltd Competitive Strengths & Weaknesses
    Table 103. Orchard Therapeutics Plc Basic Information, Manufacturing Base and Competitors
    Table 104. Orchard Therapeutics Plc Major Business
    Table 105. Orchard Therapeutics Plc Alpha L-Iduronidase Product and Services
    Table 106. Orchard Therapeutics Plc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Orchard Therapeutics Plc Recent Developments/Updates
    Table 108. Orchard Therapeutics Plc Competitive Strengths & Weaknesses
    Table 109. Ossianix Inc Basic Information, Manufacturing Base and Competitors
    Table 110. Ossianix Inc Major Business
    Table 111. Ossianix Inc Alpha L-Iduronidase Product and Services
    Table 112. Ossianix Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Ossianix Inc Recent Developments/Updates
    Table 114. Ossianix Inc Competitive Strengths & Weaknesses
    Table 115. Rain Bio Inc Basic Information, Manufacturing Base and Competitors
    Table 116. Rain Bio Inc Major Business
    Table 117. Rain Bio Inc Alpha L-Iduronidase Product and Services
    Table 118. Rain Bio Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Rain Bio Inc Recent Developments/Updates
    Table 120. Rain Bio Inc Competitive Strengths & Weaknesses
    Table 121. RegenxBio Inc Basic Information, Manufacturing Base and Competitors
    Table 122. RegenxBio Inc Major Business
    Table 123. RegenxBio Inc Alpha L-Iduronidase Product and Services
    Table 124. RegenxBio Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. RegenxBio Inc Recent Developments/Updates
    Table 126. Tega Therapeutics Inc Basic Information, Manufacturing Base and Competitors
    Table 127. Tega Therapeutics Inc Major Business
    Table 128. Tega Therapeutics Inc Alpha L-Iduronidase Product and Services
    Table 129. Tega Therapeutics Inc Alpha L-Iduronidase Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Alpha L-Iduronidase Upstream (Raw Materials)
    Table 131. Alpha L-Iduronidase Typical Customers
    Table 132. Alpha L-Iduronidase Typical Distributors
List of Figure
    Figure 1. Alpha L-Iduronidase Picture
    Figure 2. World Alpha L-Iduronidase Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Alpha L-Iduronidase Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Alpha L-Iduronidase Production (2018-2029) & (K Units)
    Figure 5. World Alpha L-Iduronidase Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Alpha L-Iduronidase Production Value Market Share by Region (2018-2029)
    Figure 7. World Alpha L-Iduronidase Production Market Share by Region (2018-2029)
    Figure 8. North America Alpha L-Iduronidase Production (2018-2029) & (K Units)
    Figure 9. Europe Alpha L-Iduronidase Production (2018-2029) & (K Units)
    Figure 10. China Alpha L-Iduronidase Production (2018-2029) & (K Units)
    Figure 11. Japan Alpha L-Iduronidase Production (2018-2029) & (K Units)
    Figure 12. Alpha L-Iduronidase Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 15. World Alpha L-Iduronidase Consumption Market Share by Region (2018-2029)
    Figure 16. United States Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 17. China Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 18. Europe Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 19. Japan Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 22. India Alpha L-Iduronidase Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Alpha L-Iduronidase by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Alpha L-Iduronidase Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Alpha L-Iduronidase Markets in 2022
    Figure 26. United States VS China: Alpha L-Iduronidase Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Alpha L-Iduronidase Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Alpha L-Iduronidase Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Alpha L-Iduronidase Production Market Share 2022
    Figure 30. China Based Manufacturers Alpha L-Iduronidase Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Alpha L-Iduronidase Production Market Share 2022
    Figure 32. World Alpha L-Iduronidase Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Alpha L-Iduronidase Production Value Market Share by Type in 2022
    Figure 34. IDUA
    Figure 35. EC 3.2.1.76
    Figure 36. World Alpha L-Iduronidase Production Market Share by Type (2018-2029)
    Figure 37. World Alpha L-Iduronidase Production Value Market Share by Type (2018-2029)
    Figure 38. World Alpha L-Iduronidase Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Alpha L-Iduronidase Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Alpha L-Iduronidase Production Value Market Share by Application in 2022
    Figure 41. Oncology
    Figure 42. Dermatology
    Figure 43. Immunology
    Figure 44. Musculoskeletal Disorders
    Figure 45. World Alpha L-Iduronidase Production Market Share by Application (2018-2029)
    Figure 46. World Alpha L-Iduronidase Production Value Market Share by Application (2018-2029)
    Figure 47. World Alpha L-Iduronidase Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Alpha L-Iduronidase Industry Chain
    Figure 49. Alpha L-Iduronidase Procurement Model
    Figure 50. Alpha L-Iduronidase Sales Model
    Figure 51. Alpha L-Iduronidase Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc

Related Reports

Global Alpha L-Iduronidase Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Alpha L-Iduronidase Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date Pharma & Healthcare

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).

Global Alpha L-Iduronidase Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Alpha L-Iduronidase Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Alpha L-Iduronidase market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Alpha L-Iduronidase Supply, Demand and Key Producers, 2024-2030

Global Alpha L-Iduronidase Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

The global Alpha L-Iduronidase market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>